GlobalData on MSN
J&J reports positive data for Erda-iDRS in bladder cancer
Erda-iDRS delivers erdafitinib into the bladder over three months, enabling localised therapy and reducing systemic exposure.
For Grant Nerren, 2025 was a busy year, full of highs and lows that likely contributed to a certain level of stress. Life was ...
The phase 2, single-arm INDIBLADE trial assessed induction ipilimumab plus nivolumab followed by CRT in patients with MIBC.
Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces two "trial in progress" presentations at the 2026 European Association of Urology congress (EAU) in London, UK. These trials investigate ...
This is a rare opportunity for me personally, this is my only hope to extend my life by any real period at all." ...
Scottsdale leaders approved a program that will provide cancer screenings to local firefighters who are often exposed to numerous carcinogens.
A consultant urological surgeon has explained why you need to prepare before a cancer check ...
Business Daily Africa on MSN
The Sh1 million-a-dose new prostate cancer treatment
Men with aggressive prostate cancer, often left with few options after chemotherapy fails, now have access to a new treatment that uses a radioactive substance.The new treatment, Lutetium-177 PSMA ...
Bladder cancer is often discovered because a person notices blood in their urine. For many patients, this is the first warning sign that something is wrong. Seeing this change usually encourages ...
Explore new findings on bladder cancer and inflammation's role in immune suppression. Discover insights to improve treatment.
The combination of nogapendekin alfa inbakicept-pmln (Anktiva) and Bacillus Calmette-Guérin was added to the NCCN clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results